FMS - Company ID 0001333141
The table below shows Fresenius Medical Care AG's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 |
|---|---|---|---|---|---|---|
| Operating cash flow | $2.14B | $1.96B | $1.86B | $2.03B | $2.04B | $1.45B |
| Capital expenditure | $1.03B | $952.94M | $931.63M | $747.94M | $675.31M | $597.86M |
| Investing cash flow | -$1.38B | -$1.00B | -$2.69B | -$1.21B | -$2.28B | -$2.35B |
| Dividends paid | -$277.18M | -$263.24M | -$317.90M | -$296.13M |
Fresenius Medical Care AG reported operating cash flow of $2.14B for fiscal year 2016. That is up 9.2% from $1.96B in fiscal 2015. Over the 10 fiscal years shown, operating cash flow grew from $1.20B (FY 2007) to $2.14B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $271.73M |
| $280.65M |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$584.76M | -$1.01B | $805.01M | -$808.04M | $468.34M | $793.16M |